Logo image of CCL-B.CA

CCL INDUSTRIES INC - CL B (CCL-B.CA) Stock Fundamental Analysis

TSX:CCL-B - Toronto Stock Exchange - CA1249003098 - Common Stock - Currency: CAD

76.16  -1.29 (-1.67%)

Fundamental Rating

6

Overall CCL-B gets a fundamental rating of 6 out of 10. We evaluated CCL-B against 9 industry peers in the Containers & Packaging industry. CCL-B scores excellent on profitability, but there are some minor concerns on its financial health. CCL-B has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CCL-B was profitable.
In the past year CCL-B had a positive cash flow from operations.
Each year in the past 5 years CCL-B has been profitable.
CCL-B had a positive operating cash flow in each of the past 5 years.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

CCL-B's Return On Assets of 8.42% is fine compared to the rest of the industry. CCL-B outperforms 77.78% of its industry peers.
The Return On Equity of CCL-B (15.73%) is better than 88.89% of its industry peers.
CCL-B has a better Return On Invested Capital (9.53%) than 88.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CCL-B is in line with the industry average of 8.56%.
The 3 year average ROIC (9.32%) for CCL-B is below the current ROIC(9.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.42%
ROE 15.73%
ROIC 9.53%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 11.61%, CCL-B belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
CCL-B's Profit Margin has improved in the last couple of years.
CCL-B has a Operating Margin of 14.83%. This is amongst the best in the industry. CCL-B outperforms 88.89% of its industry peers.
CCL-B's Operating Margin has been stable in the last couple of years.
CCL-B has a Gross Margin of 29.68%. This is comparable to the rest of the industry: CCL-B outperforms 55.56% of its industry peers.
CCL-B's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.83%
PM (TTM) 11.61%
GM 29.68%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCL-B is creating some value.
Compared to 1 year ago, CCL-B has less shares outstanding
The number of shares outstanding for CCL-B has been reduced compared to 5 years ago.
CCL-B has a better debt/assets ratio than last year.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CCL-B has an Altman-Z score of 3.59. This indicates that CCL-B is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.59, CCL-B is in line with its industry, outperforming 55.56% of the companies in the same industry.
CCL-B has a debt to FCF ratio of 3.97. This is a good value and a sign of high solvency as CCL-B would need 3.97 years to pay back of all of its debts.
CCL-B has a Debt to FCF ratio (3.97) which is in line with its industry peers.
CCL-B has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CCL-B (0.46) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.97
Altman-Z 3.59
ROIC/WACC1.36
WACC7.03%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 2.13 indicates that CCL-B has no problem at all paying its short term obligations.
CCL-B's Current ratio of 2.13 is in line compared to the rest of the industry. CCL-B outperforms 44.44% of its industry peers.
CCL-B has a Quick Ratio of 1.55. This is a normal value and indicates that CCL-B is financially healthy and should not expect problems in meeting its short term obligations.
CCL-B has a better Quick ratio (1.55) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.55
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.23% over the past year.
Measured over the past years, CCL-B shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.99% on average per year.
The Revenue has grown by 9.80% in the past year. This is quite good.
The Revenue has been growing slightly by 6.37% on average over the past years.
EPS 1Y (TTM)32.23%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%9.35%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%8.63%

3.2 Future

CCL-B is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.26% yearly.
Based on estimates for the next years, CCL-B will show a small growth in Revenue. The Revenue will grow by 4.63% on average per year.
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue Next Year5.67%
Revenue Next 2Y4.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.87 indicates a correct valuation of CCL-B.
Based on the Price/Earnings ratio, CCL-B is valued a bit more expensive than 66.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.82. CCL-B is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 15.31 indicates a correct valuation of CCL-B.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCL-B is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CCL-B to the average of the S&P500 Index (36.21), we can say CCL-B is valued rather cheaply.
Industry RankSector Rank
PE 15.87
Fwd PE 15.31
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCL-B indicates a slightly more expensive valuation: CCL-B is more expensive than 66.67% of the companies listed in the same industry.
CCL-B's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 20.49
EV/EBITDA 9.78
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The excellent profitability rating of CCL-B may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.44
EPS Next 2Y2.88%
EPS Next 3Y8.26%

5

5. Dividend

5.1 Amount

CCL-B has a Yearly Dividend Yield of 1.65%. Purely for dividend investing, there may be better candidates out there.
CCL-B's Dividend Yield is comparable with the industry average which is at 3.14.
CCL-B's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.65%

5.2 History

On average, the dividend of CCL-B grows each year by 11.36%, which is quite nice.
CCL-B has paid a dividend for at least 10 years, which is a reliable track record.
CCL-B has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.36%
Div Incr Years23
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CCL-B pays out 24.59% of its income as dividend. This is a sustainable payout ratio.
CCL-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP24.59%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

CCL INDUSTRIES INC - CL B

TSX:CCL-B (8/1/2025, 7:00:00 PM)

76.16

-1.29 (-1.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-13 2025-08-13
Inst Owners39.72%
Inst Owner ChangeN/A
Ins Owners1.91%
Ins Owner ChangeN/A
Market Cap13.28B
Analysts82.11
Price Target93.43 (22.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.65%
Yearly Dividend1.16
Dividend Growth(5Y)11.36%
DP24.59%
Div Incr Years23
Div Non Decr Years34
Ex-Date06-13 2025-06-13 (0.32)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.41%
Min EPS beat(2)-1.39%
Max EPS beat(2)4.21%
EPS beat(4)2
Avg EPS beat(4)10.9%
Min EPS beat(4)-5.47%
Max EPS beat(4)46.26%
EPS beat(8)3
Avg EPS beat(8)2.39%
EPS beat(12)5
Avg EPS beat(12)1.9%
EPS beat(16)8
Avg EPS beat(16)2.43%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.94%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)1.57%
Revenue beat(8)1
Avg Revenue beat(8)-1.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.72%
Revenue beat(16)6
Avg Revenue beat(16)-1.07%
PT rev (1m)0.33%
PT rev (3m)2.23%
EPS NQ rev (1m)1%
EPS NQ rev (3m)-0.74%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 15.87
Fwd PE 15.31
P/S 1.8
P/FCF 20.49
P/OCF 12.7
P/B 2.43
P/tB 7.61
EV/EBITDA 9.78
EPS(TTM)4.8
EY6.3%
EPS(NY)4.97
Fwd EY6.53%
FCF(TTM)3.72
FCFY4.88%
OCF(TTM)6
OCFY7.87%
SpS42.41
BVpS31.3
TBVpS10.01
PEG (NY)N/A
PEG (5Y)1.44
Profitability
Industry RankSector Rank
ROA 8.42%
ROE 15.73%
ROCE 12.66%
ROIC 9.53%
ROICexc 10.53%
ROICexgc 19.98%
OM 14.83%
PM (TTM) 11.61%
GM 29.68%
FCFM 8.76%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
ROICexc(3y)10.42%
ROICexc(5y)10.66%
ROICexgc(3y)20.67%
ROICexgc(5y)21.9%
ROCE(3y)12.39%
ROCE(5y)12.67%
ROICexcg growth 3Y-4.22%
ROICexcg growth 5Y-2.39%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-0.08%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
F-Score8
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.97
Debt/EBITDA 1.64
Cap/Depr 90.23%
Cap/Sales 5.37%
Interest Coverage 19.01
Cash Conversion 68.02%
Profit Quality 75.5%
Current Ratio 2.13
Quick Ratio 1.55
Altman-Z 3.59
F-Score8
WACC7.03%
ROIC/WACC1.36
Cap/Depr(3y)114.57%
Cap/Depr(5y)103.99%
Cap/Sales(3y)6.78%
Cap/Sales(5y)6.27%
Profit Quality(3y)87.06%
Profit Quality(5y)92.08%
High Growth Momentum
Growth
EPS 1Y (TTM)32.23%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%9.35%
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue 1Y (TTM)9.8%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%8.63%
Revenue Next Year5.67%
Revenue Next 2Y4.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.05%
EBIT growth 3Y8.62%
EBIT growth 5Y7.62%
EBIT Next Year41.68%
EBIT Next 3Y15.95%
EBIT Next 5YN/A
FCF growth 1Y32.16%
FCF growth 3Y5.34%
FCF growth 5Y6.76%
OCF growth 1Y8.38%
OCF growth 3Y8.25%
OCF growth 5Y6.42%